What adverse effects did Brianne Dressen experience after participating in the AstraZeneca COVID-19 vaccine trial?

Brianne Dressen experienced severe and immediate neurological complications after receiving the AstraZeneca COVID-19 vaccine during the phase three trial. Within an hour of injection, she developed tingling in her arm, followed by blurred and double vision, auditory distortions, and mobility issues including leg weakness that caused her to walk into doorways. Despite being assured of medical and financial support for research-related injuries, Dressen faced inadequate care from the pharmaceutical company. Her experience highlights critical gaps in vaccine trial participant support and the need for greater transparency in reporting adverse effects during clinical trials.